Shanghai, China

Yuchi Ma


 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Yuchi Ma: Pioneering Pyridine Compounds for Pharmaceuticals

Introduction: Yuchi Ma, an inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals through his innovative work on five-member-heterocycle fused pyridine compounds. His research focuses on developing compounds that have the potential to address critical medical challenges.

Latest Patents: Yuchi Ma holds a patent for his invention titled "Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereof." This groundbreaking invention provides a class of five-member-heterocycle fused pyridine compounds, their pharmaceutically acceptable salts, and solvates. The patent outlines a method for producing these compounds, pharmaceutical compositions containing them, and their use in creating medicaments aimed at preventing and treating diseases and tumors associated with abnormal protein tyrosine kinase activity.

Career Highlights: Yuchi Ma has worked with prestigious research institutions and companies, including the Chinese Academy of Sciences and Shanghai Haihe Pharmaceutical Co., Ltd. His experience in these organizations has enriched his knowledge and skills in pharmaceutical innovation, particularly in the synthesis of chemical compounds.

Collaborations: Throughout his career, Yuchi has collaborated with notable professionals in the field, including Jingkang Shen and Meiyu Geng. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion: Yuchi Ma is an exemplary inventor whose work on fused pyridine compounds exemplifies the intersection of chemistry and medicine. His innovative approach to creating effective pharmaceutical compositions positions him as a valuable contributor to the field, with the potential to make a substantial impact on the treatment of diseases linked to abnormal protein tyrosine kinase.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…